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Abstract
Conventional non-viral gene transfer uses bacterial plasmid DNA containing antibiotic resistance genes, cis-acting bacterial
sequence elements, and prokaryotic methylation patterns that may adversely affect transgene expression and vector
stability in vivo. Here, we describe novel replicative forms of a eukaryotic vector DNA that consist solely of an expression
cassette flanked by adeno-associated virus (AAV) inverted terminal repeats. Extensive structural analyses revealed that this
AAV-derived vector DNA consists of linear, duplex molecules with covalently closed ends (termed closed-ended, linear
duplex, or ‘‘CELiD’’, DNA). CELiD vectors, produced in Sf9 insect cells, require AAV rep gene expression for amplification.
Amounts of CELiD DNA produced from insect cell lines stably transfected with an ITR-flanked transgene exceeded 60 mg
per 56109 Sf9 cells, and 1–15 mg from a comparable number of parental Sf9 cells in which the transgene was introduced
via recombinant baculovirus infection. In mice, systemically delivered CELiD DNA resulted in long-term, stable transgene
expression in the liver. CELiD vectors represent a novel eukaryotic alternative to bacterial plasmid DNA.
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Introduction
Non-viral gene transfer typically uses bacterial plasmids to
introduce foreign DNA into recipient cells. In addition to the
transgene of interest, such DNAs routinely contain extraneous
sequence elements needed for selection and amplification of the
plasmid DNA (pDNA) in bacteria, such as antibiotic resistance
genes and a prokaryotic origin of replication. Also, bacterial DNA
preparations often contain endotoxin that can reduce gene transfer
efficiency [1]. Ideally, DNA for non-viral gene transfer would
contain only the gene of interest, be devoid of prokaryotic
modifications that can trigger an innate immune response
[1,2,3,4], be in an exonuclease-resistant form, and lack detectable
endotoxin contamination. Transgene persistence is also highly
desirable for many gene therapy applications. We have observed
that transgenes flanked by inverted terminal repeats (ITRs) from
adeno-associated virus type 2 (AAV) can be amplified to high copy
number in Spodoptera frugiperda (Sf9) cells in the presence of a
recombinant baculovirus expressing the AAV replication proteins,
Rep78 and Rep52. DNA produced in this manner consists solely
of a transgene of interest with flanking AAV ITRs, and, since it is
produced in eukaryotic cells, is devoid of prokaryotic DNA
modifications and bacterial endotoxin contamination. Structural
characterization revealed the ITR-flanked transgenes as exonu-
clease-resistant, linear DNA molecules with covalently closed ends.
We have termed these closed-ended, linear duplex molecules
‘‘CELiD’’ DNA.
CELiD DNA is produced in Sf9 cells upon co-infection with two
separate baculovirus expression vectors (BEVs): the first BEV
bearing an ITR-flanked transgene, and a second BEV (designated
Bac-Rep) encoding AAV non-structural proteins (Rep78 and
Rep52) essential for ITR-mediated DNA replication. Alternative-
ly, CELiD DNA can be rescued and amplified upon Bac-Rep
infection of clonal Sf9 cell lines bearing a stably integrated rAAV
vector genome. The structure of replicated ITR-flanked transgene
DNA was analyzed using native and denaturing agarose gel
electrophoresis, restriction endonuclease size mapping, atomic
force microscopy (AFM), and exonuclease sensitivity assays. The
results of these orthogonal assays established that the predominant
structure of the replicated vector DNA is closed-ended, linear
duplex monomers and dimers.
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Materials and Methods
Ethics statement
The University of North Carolina at Chapel Hill Institutional
Animal Care and Use Committee (IACUC) approved the animal
study protocols.
Sf9 insect cell culture
The Spodoptera frugiperda Sf9 cell line was obtained from Life
Technologies, Corp. (Grand Island, NY, USA). Sf9 cells were
grown in suspension in serum-free media (HyQH SFX, HyClone,
Logan, UT, USA). Cultures were maintained within vented-cap,
polycarbonate Erlenmeyer flasks (Corning, Inc., Corning, NY,
USA) in an orbital platform shaker (135 rpm agitation) at 27uC
in ambient atmosphere. Cell density, size and viability were
assessed using an automated cell counter (Cellometer, Nexcelom
Bioscience, Lawrence, MA, USA) or flow cytometry (Guava
EasyCyte Mini, Millipore Corp., Billerica, MA, USA).
Plasmid pFBGR-bsd construction
The blasticidin-S deaminase (bsd) gene (along with the Orgyia
pseudotsugata immediate early-1 (Op IE-1) and EM7 promoters)
was PCR-amplified from pIB/V5-His/CAT (Life Technologies,
Corp.) using the following primer pair: 59-ATAAGCT-
TACGCTCAGTGGAACGAAAAC-39 and 59-ATAAGCTT-
GACGTGTCAGTGTCAGTCCTGCTCCT-39. The 865 bp
PCR product was digested with HindIII (sites underlined in
primer sequence) and ligated into HindIII-digested pFBGR (5).
Establishing stable Sf9/ITR-GFP cell lines for high-yield
CELiD-GFP DNA production
Sf9 cells were transfected with pFBGR-bsd using Cellfectin
Transfection Reagent (Life Technologies, Corp.). At three days
post-transfection, antibiotic-resistant cells were selected by the
addition of blasticidin-S HCl (50 mg/ml) (Life Technologies,
Corp.) to the growth medium. After two weeks in selective
medium, blasticidin-resistant (bsdr) clones were derived by single-
cell dilution or direct colony transfer techniques. The bsdr clones
were expanded in insect cell culture medium supplemented with
10% fetal bovine serum (FBS) (HyClone) and blasticidin-S HCl
(10 mg/ml) for 2 to 3 additional passages, then returned to serum-
free medium with 10 mg/ml blasticidin-S HCl. After an additional
12 passages, blasticidin-S HCl was omitted from the medium and
the cell lines were expanded for analysis.
For functional screening, clonal Sf9/ITR-GFP cell lines were
infected (MOI = 5) with a recombinant baculovirus, Bac-Rep,
expressing the AAV type 2 Rep78 and Rep52 proteins [5] and
analyzed for induced GFP expression. Clonal Sf9/ITR-GFP cells
with the highest levels of GFP fluorescence were expanded for
CELiD-GFP DNA preparation.
Figure 1. Schematic representation of plasmid DNA used for producing stable cell lines. Plasmid pFBGR-bsd contains the GFP gene under
the dual control of the cytomegalovirus IE promoter (CMV) and baculovirus p10 promoter (p10) flanked by AAV-2 inverted terminal repeats (ITR). bla,
b-lactamase (ampicillicin-resistance gene). bsd, blasticidin-S deaminase gene. ColE1, bacterial origin of replication. (Lower) Linear illustration of
pFBGR-bsd indicates the rescued forms of the ITR-flanked transgene. The linear, single-stranded AAV virion genome is represented by a solid thin line
flanked by the inverted terminal repeats (ITRs, filled rectangles). The duplex CELiD-vector DNA is represented by the open rectangle flanked by AAV
ITRs.
doi:10.1371/journal.pone.0069879.g001
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Production and purification of CELiD-GFP DNA from a
clonal Sf9/ITR-GFP cell line
Clonal Sf9/ITR-GFP cells were seeded at 26106 cells/mL and
infected with Bac-Rep (MOI = 1 to 3). Cell viability and diameter
were monitored daily until the cell diameter increased to 18–
20 mm (uninfected cell diameter 14–15 mm), indicating that the
cells were in the late stages of the viral infection. Extrachromo-
somal DNA was extracted from the Bac-Rep-infected, Sf9/ITR-
Figure 2. AAV Rep protein-dependent expression of GFP. (A) Induction of GFP expression in blasticidin-S resistant Sf9/ITR-GFP cells in
response to Bac-Rep infection. The clonal Sf9/ITR-GFP cell line contains a stably integrated copy of pFBGR-bsd. Uninfected cells or cells infected with
wild-type baculovirus (Bac-AcNPV) lack detectable GFP expression as determined by FACS analysis. (upper row, 0% GFP positive cells). Addition of
Bac-Rep inoculum (0.5%, 1.0%, and 1.5%; v:v) resulted in a dose-dependent increase in the number of GFP-positive cells (lower row). Images were
obtained 3 days after infection. Magnification, 10x objective used for all images. (B) Quantitative analysis of GFP induction as a function of Bac-Rep
dose. Cells exposed to increasing doses of Bac-Rep were harvested on day 3 post-infection. Fluorescent emission intensities were assessed from
equivalent amounts of cell lysates (80 mg protein), using the fluorescent reader function of a real-time thermocycler (excitation 450–490 nm; emission
515–530 nm) (upper panel), *** indicates t-test significance (p,0.001). The relative fold-increase in GFP fluorescence is indicated by the values next
to each bar. Protein concentrations were determined in the lysates and approximately 120 mg of each sample was fractionated electrophoretically
using SDS-polyacrylamide gels. Proteins were electroblotted onto nitrocellulose membranes for western blot detection of GFP, Rep52, gp64, and
GAPDH (used as a protein loading and transfer standard, lower panel). Relative levels of protein are indicated by the values above the protein band.
(C) Analysis of the increase of GFP-vector DNA in response to Bac-Rep infection. Low molecular weight DNA was recovered from the cells and the
quantity of GFP vector genomes determined using real-time qPCR (upper panel). Both the uninfected cell control and the wild-type baculovirus-
infected cell control lysates produced a relatively low PCR signal (150 and 175 copies per cell, respectively). The GFP vector DNA copy number
increased to 21087 copies per cell with 0.5% (v:v) Bac-Rep. At 1% (v:v) Bac-Rep, the copy number increased to 28862 copies per cell and 1.5% (v:v)
Bac-Rep increased the copy number to 38286 per cell. The statistical significance was determined by Student’s t-test. ***, p,0.001. Lower panel – The
samples were analyzed by agarose-ethidium bromide gel electrophoresis (1% agarose). No detectable CELiD DNA was recovered from uninfected
cells. A band .10 kb appears in lysates from all baculovirus-infected cells. (D) Time-course of GFP fluorescence. Sf9/ITR-GFP cells were inoculated
with either wtBac (Bac-ACNPV) or Bac-Rep (0.5%, 1%, and 1.5% (v:v)). GFP fluorescence was measured for the indicated cellular lysate at 1, 2, and
3 days post-infection.
doi:10.1371/journal.pone.0069879.g002
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GFP cells using a commercially available plasmid isolation kit
(Qiagen, Valencia, CA, USA). CELiD production was monitored
by agarose gel electrophoresis and ethidium bromide staining of
extrachromosomal DNA. The presence of a 2.7 kb band after
Bac-Rep infection indicated that the ‘‘proviral’’ rAAV-GFP
genome was rescued from chromosomal DNA and amplified as
an episomal element.
CELiD DNA production in parental Sf9 cells
CELiD DNA was produced in parental Sf9 cells by co-
infection with two separate baculovirus expression vectors (BEV):
Bac-Rep and a second BEV bearing an ITR-flanked transgene,
such as Bac-GFP or Bac-LacZnls. Infected Sf9 cells were
harvested once the mean cell diameter increased by 4–5 mm
and the percent viability decreased to 80–90%. CELiD DNA was
isolated using a commercially available plasmid purification kit
(Qiagen).
Construction of pFB-TBG-GFP and baculovirus
production
A thyroxine-binding globulin promoter (TBG)-GFP cassette
(1797 bp) was isolated from pENN AAV TBG PI-eGFP (kindly
provided by Dr. Charles P. Venditti, NHGRI, NIH) following
digestion with NheI and PspXI. The ca. 1800 bp TBG-eGFP
fragment was transferred into the backbone of pFBGR after the
GFP transcription cassette was removed from pFBGR by
digestion with SpeI and XhoI (retaining the AAV2 ITRs and
transposase Tn7 recombination signals). The resulting pFB-TBG-
GFP (7074 bp) plasmid consists of the AAV2 ITRs flanking the
TBG promoter and GFP open reading frame. Recombinant
baculovirus stocks were generated using the Bac-to-Bac System
(Life Technologies, Corp.) with modifications to the plasmids
previously described [5]. Briefly, competent E. coli DH10Bac cells
were transformed with pFB-TBG-GFP. Following selection on
triple antibiotic agar plates (containing 50 mg/ml kanamycin,
7 mg/ml gentamicin, 10 mg/ml tetracycline, and X-gal 100 mg/
ml), several white colonies were picked and expanded in small
volume cultures. Bacmid DNA was extracted and used to
transfect Sf9 cells. Three days after transfection, baculovirus-
containing supernatant (passage 1 or ‘‘P1’’) was expanded two
more rounds by adding infected-cell supernatant to fresh Sf9 cells
(1:100; v:v). Infected cells were cryopreserved at P3, and served
as a source of infectious baculovirus as previously described [6].
Construction of pFB-CMV-LacZnls and baculovirus
production
Plasmid pFB-CMV-LacZnls was produced by isolating the
4.1 kb LacZnls gene (encoding a nuclear-localized b-galactosidase
protein) from XbaI- and SalI-digested pAAV2.1-CM (pCMV-
LacZnls), kindly provided by Dr. Xiao Xiao (UNC-Chapel Hill,
Chapel Hill, NC), and ligating this fragment to the 5.2 kb
fragment of SpeI- and XhoI-digested pFBGR, thus replacing the
GFP reporter gene with LacZnls coding sequences. Competent
DH10Bac cells (Life Technologies, Corp.) were transformed with
pFB-CMV-LacZnls to yield Bac-LacZnls bacmid DNA. Recom-
binant Bac-LacZnls bacmid isolates were identified by PCR
screening using M13/pUC reverse sequencing primer (59-
AGCGGATAACAATTTCACACAGG-39) and a synthetic LacZ
insert primer (59-CGAGAAGTACTAGAGGATCA-39). Bacmid
DNA was transfected into Sf9 cells to yield an infectious
baculovirus, Bac-LacZnls, which was further amplified by serial
passage in Sf9 cells.
Figure 3. Rate of GFP vector DNA accumulation. (A). Cells were inoculated with 1% (v:v) Bac-Rep stock and sampled at 6, 28, 54, 77, and 168 hr
post-infection. The GFP-vector DNA content was determined by qPCR (upper panel). The doubling time of the GFP vector DNA was determined using
the following algorithm: tD = (t2–t1) log 2/log (t2/t1), where tD is the doubling time and tn is the GFP copy number at a given time point. The tD
(28 hr) = 2.8 hr, tD (54 hr) = 11.5 hr, and tD (77 hr) = 18.7 hr. (B) Time course of protein expression in Sf9/ITR-GFP cells. GFP fluorescence was
measured in cell lysates obtained from the time-course described in (A) (upper panel). Aliquots from each time point were fractionated on SDS-
polyacrylamide gels and transferred to nitrocellulose membranes for western blot analysis to detect Rep proteins, GFP proteins, gp64, and GAPDH
(used as a loading and transfer control).
doi:10.1371/journal.pone.0069879.g003
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Figure 4. Native and denaturing agarose gel electrophoresis of CELiD-GFP DNA. (A) Native agarose gel electrophoresis (0.4% agarose, 1x
TAE buffer). CELiD DNA resolved as a 2.7 kb monomer and associated multimeric concatomers. Lane 1: CELiD-GFP DNA produced from co-infecting
parental Sf9 cells with Bac-Rep and a baculovirus bearing an AAV ITR-flanked GFP cassette, Bac-GFP. Lane 2: CELiD-GFP DNA produced from an Sf9/
ITR-GFP cell line bearing a stably integrated AAV GFP vector genome. M: 1 kb DNA ladder. HR: high-range DNA ladder. The positions of various
replicative-form CELiD DNAs are indicated: monomer, dimer, trimer, and tetramer. (B) Denaturing agarose gel electrophoresis (0.7% alkaline agarose).
CELiD-GFP DNA conformers appear predominantly as a 5.4 kb band, with dimer and higher order forms detectable. (C) Restriction map. Restriction
endonuclease AgeI has one recognition site in the CELiD monomer, generating two fragments of 1801 bp and 867 bp, respectively. Schematic
representation of the AgeI recognition site(s) in the monomer (1x), dimer (2x) and multimer (3x and 4x) forms of CELiD-GFP DNA. CELiD-GFP
monomer: 2668 bp. The black rectangles indicate the positions of the AAV 59 ITRs, and the gray rectangles indicate the positions of the AAV 39 ITRs.
The two dimer figures represent tail-to-tail and head-to-head configurations. The predicted DNA length and fragments are indicated. Top right,
CELiD DNA for Non-Viral Gene Transfer
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Denaturing agarose gel electrophoresis
Alkaline (denaturing) agarose gels were prepared by dissolving
agarose (SeaKem LE agarose, BioWhittaker Molecular Applica-
tions, Rockland, ME, USA) in boiling water and cooling to near
gelling temperature. Alkaline gel solution concentrate (10x) was
added to a 1x final concentration just before the gels were poured.
The 1x alkaline gel running buffer and gel solution composition is:
50 mM NaOH, 1 mM EDTA. Using 10x concentrate, DNA
samples were adjusted to 1x alkaline gel solution conditions and
supplemented with 2.5% Ficoll-400 and 0.05% bromophenol
blue. Electrophoresis was performed at constant voltage (30–60 V)
for 3–6 hr.
Time-course analysis and requirements for CELiD rescue
and amplification in Sf9 cells
Clonal Sf9/ITR-GFP cells were inoculated with various
amounts of Bac-Rep stock. Periodically, cells were harvested and
extrachromosomal DNA was recovered using a commercially
available DNA isolation kit (Qiagen Plasmid Mini Kit). Extracted
DNA was examined by either agarose gel electrophoresis or by
PCR with GFP-specific primer pairs for quantitative determina-
tion of CELiD DNA amounts.
For western blotting, cell proteins were fractionated by SDS-
polyacrylamide gel electrophoresis and transferred to nitrocellu-
lose membranes. The membranes were incubated in blocking
buffer (BB) composed of 5% non-fat dry milk (w:v) in phosphate-
buffered saline plus 0.05% Tween-20 (PBST) for 1 hr at ambient
temperature with orbital agitation. After washing the membranes
in wash buffer (WB) composed of 3% non-fat dry milk in PBST,
membranes were incubated with the appropriate primary
antibody solution (diluted in BB) either at ambient temperature
(1 hr) or 4uC (overnight) with continuous orbital agitation. The
following primary antibodies and dilution ratios were used: 1. anti-
AAV Rep mouse monoclonal antibody (mAb) 303.9 (American
Research Products, Inc., Waltham, MA, USA), 1:200 dilution. 2.
anti-baculovirus envelope glycoprotein gp64 mouse mAb
(eBioscience San Diego, CA, USA), 1:1000 dilution. 3. anti-
GAPDH mAb (Ambion, Life Technologies, Corp.), 1:5000
dilution. 4. HRP-conjugated anti-GFP mAb (Fitzgerald Industries
International, Acton, MA, USA), 1:5000 dilution. After incuba-
tion, primary antibody solutions were removed and membranes
were washed in WB (365 mins). Non-conjugated mAbs were
incubated with secondary antibody solution (goat, anti-mouse
horseradish peroxidase (HRP)-conjugate (1:5000) (Sigma, St.
Louis, MO, USA) for 1 hr, and then washed with WB as above.
HRP activity was detected by enhanced chemiluminescence (ECL)
(SuperSignal West Dura chemiluminescent substrate, Thermo
Scientific, Rockford, IL, USA). Images were acquired using a
digital gel documentation instrument (G:Box Chemi, Syngene
USA, Frederick, MD, USA).
images of native (1% agarose, TBE buffer) and denaturing (0.7% agarose, alkaline buffer) agarose gel electrophoresis of AgeI-digested CELiD-GFP
DNA. ‘‘2’’ indicates uncut CELiD-GFP DNA, ‘‘+’’ indicates AgeI-digested DNA.
doi:10.1371/journal.pone.0069879.g004
Figure 5. CELiD-GFP DNA sensitivity to exonuclease I and exonuclease III. E. coli exonuclease III (ExoIII) removes nucleotides processively (39
–.59) from DNA initiating at a 39-OH of either blunt-ended or 59 protruding duplex DNA. E. coli exonuclease I (ExoI) degrades single-stranded DNA
processively in a 39 to 59 direction. (A) Total CELiD DNA (1 mg) was incubated with either ExoI (20 units) or ExoIII (100 units), either without prior
restriction enzyme (RE) digestion (left) or following RE digestion (right). Lane M: DNA size ladder. Lane 1: untreated CELiD DNA. Lane 2: CELiD DNA
treated with ExoI. Lane 3: CELiD DNA treated with ExoIII. Lane 4: untreated CELiD DNA. Samples in lanes 5, 6, 7 were digested with NaeI prior to
exonuclease treatment. Lane 5: no exonuclease control. Lane 6: ExoI treatment. Lane7: ExoIII treatment. (B) Additional substrates as controls for ExoI
activity. The wX174 virus genome is a 5386 nt, single-stranded, closed circular DNA molecule. ExoI treatment is indicated above each lane by a ‘‘+’’ or
‘‘–’’ sign. Lanes 1 and 2: wX174 DNA. Lanes 3 and 4: wX174 DNA digested with HaeIII. Lanes 5 and 6: CELiD DNA. Lanes 7 and 8: single-stranded
synthetic oligonucleotide (25mer). Lanes 9 and 10: Mixed CELiD DNA and 25mer.
doi:10.1371/journal.pone.0069879.g005
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Figure 6. AFM images of CELiD vector DNA chains adsorbed onto APS-treated mica. (A) Typical images of the CELiD-GFP monomer
deposited from aqueous solution (dH2O). The monomer is indistinguishable from standard double-stranded, linear DNA. All images are 4506450 nm.
(B) CELiD-GFP monomers adsorbed onto mica substrate immediately after being exposed to denaturing conditions. The height of the chain is about
half that of the native monomer chain confirming that the loops are single-stranded. These monomers are closed loops with randomly located,
condensed regions (brighter spots along the loops). The lengths of these loops are consistent with denatured monomers supporting the model of a
covalently closed, duplex conformation under native conditions. Top images are of the denatured monomers. Bottom images show the
corresponding traced loops. (C) Images of individual CELiD-GFP dimers adsorbed from H2O. The chains are double-stranded, linear DNA with lengths
twice that of the monomer and exhibit a characteristic conformation with three condensed regions, one located centrally and the other two at
opposite ends of the molecule. (D) Under high salt conditions (0.5 M NaCl), the condensed regions of the CELiD-GFP dimer relax and the chains take
on conformations typical of double-stranded, linear DNA with length twice that of the monomer CELiD vector DNA. Numbers in yellow indicate the
chain length in bp, estimated by path tracing.
doi:10.1371/journal.pone.0069879.g006
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Atomic force microscopy (AFM) imaging of CELiD–GFP
DNA
The 2.7 kb monomer and 5.4 kb dimer CELiD–GFP replica-
tive-form DNAs were purified from gel slices following agarose gel
electrophoresis (using QIAEX II gel extraction kit, Qiagen) and
dissolved in molecular biology grade H2O (Quality Biological,
Inc., Gaithersburg, MD, USA).
Prior to applying the DNA samples, AFM mica substrates
were modified with aminopropylsilatrane (APS). APS solution
(,150 nM in 50 ml) was applied to freshly cleaved mica disks
(12 mm diameter) for 30 minutes at ,20uC. The disks were then
rinsed thoroughly with dH2O and dried in a nitrogen stream.
DNA solutions of appropriate concentrations (typically, on the
order of 1 mM base-pair concentration) were applied to the APS-
treated mica and incubated approximately 10 min at room
temperature. The samples were then gently rinsed with dH2O
and dried in an argon stream before imaging.
The effects of different solvents on the topological features of the
sample DNA were examined by AFM using: 1. Buffered saline
(500 mM NaCl and 20 mM HEPES, pH 7.4), 2. 50% formamide
(sample heated at 60uC for 30 minutes to denature the DNA), and
3. Water (dH2O).
Samples were imaged with an AFM instrument (MultiMode-
PicoForce AFM with Nanoscope V controller, Bruker Nano,
Santa Barbara, CA, USA). Imaging was performed in oscillating
mode (tapping) under ambient conditions using silicon cantilevers
with nominal stiffness of ,42 N/m and resonance frequencies in
the 300 kHz range (OTESPA by Olympus or TESP-SS by
Bruker Nano). Imaging data were preprocessed using Nanoscope
v7.31. DNA lengths were measured using algorithms developed
in conjunction with image processing software based on NIH
ImageJ (http://rsb.info.nih.gov/ij/), Matlab (Mathworks, Natick,
MA, USA) and Origin (OriginLab, Northampton, MA, USA).
The lengths of extended DNA chains with clearly discernible
paths were determined by contour tracing. For overlapping and
entangled chains, we developed new algorithms that made use of
the volume information contained in the AFM topographic
images. Volumes were measured by adding pixel heights using
the Particle Analysis module of NIH ImageJ.
CELiD DNA expression in vitro
Transfections were conducted using either GFP or nuclear-
localized b-galactosidase (LacZnls) reporter cassettes. HEK 293
cells were seeded in 6-well tissue culture plates one day before
transfection to achieve 90% confluence at the time of use.
Transfections were performed using a commercially available
liposome-based transfection reagent (LipofectamineH 2000, Life
Technologies, Corp., Carlsbad, CA, USA) following the manu-
facturer’s suggested protocol. For GFP expression assays, HEK
293 cells were transfected using 4 ml of lipid reagent per well and
equivalent copy numbers of reporter DNA molecules: CELiD–
GFP DNA (1.48 mg per well) or plasmid-GFP DNA, pFBGR (4 mg
per well). At day 6 post-transfection, cells were examined for GFP
expression by fluorescence microscopy.
For LacZ expression assays, HEK 293 cells were seeded in 6-
well tissue culture plates and transfected with equal weight
amounts of CELiD-LacZnls (2 mg) or pFB-CMV-LacZnls (2 mg)
using 3 ml of lipid reagent per well. Three days post-transfection,
Figure 7. CELiD vector DNA expression in vitro. (A) HEK 293 cells transiently transfected with CELiD-GFP DNA or plasmid pFBGR for green
fluorescent protein (GFP) expression. Both DNAs harbor an identical gene expression cassette encoding GFP and were transfected using equivalent
copy numbers. Images were taken at day 6 post-transfection. Magnification, 10x objective (with digitally-enlarged insert). (B) HEK 293 cells transiently
transfected with equal amounts of CELiD-LacZnls DNA or plasmid pFB-CMV-LacZnls. Both DNAs harbor an identical gene expression cassette
encoding b-galactosidase with a nuclear localization signal (LacZnls). X-gal staining of cells at three days post-transfection. Magnification, 10x
objective (with digitally-enlarged insert).
doi:10.1371/journal.pone.0069879.g007
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Figure 8. In vivo gene expression and DNA copy number per diploid cell following tail vein injection of (A) CELiD-LacZnls or (B)
Plasmid-LacZnls (pCMV-LacZnls). 1 mg of CELiD DNA or 10 mg of the circular plasmid DNA was administrated by hydrodynamic tail vein injection.
Transfected livers were harvested and processed at days 1, 3, and 7, as well as 5 weeks post-injection. Histological samples were sectioned and
CELiD DNA for Non-Viral Gene Transfer
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b-galactosidase (b-gal) activity was detected by staining with the
chromogenic substrate, X-gal. Briefly, cells were rinsed with PBS,
and then fixed in 2% formaldehyde, 0.1% glutaraldehyde in PBS
for 2 minutes. After washing the cells three times with PBS, freshly
made X-gal staining buffer (1 mg/ml X-gal, 2 mM MgCl2, 5 mM
potassium ferrocyanide, and 5 mM potassium ferricyanide in PBS,
warmed to 50uC) was added, and the cells were incubated at 37uC
for 30 min to 24 hr in the dark. After incubation, samples were
washed three times (each for 5 min) in room temperature PBS,
and examined by light microscopy.
Hydrodynamic injection of DNA and in vivo gene
expression detection
Outbred male ICR mice at 2 months of age were used for
hydrodynamic DNA injection via the tail vein according to the
method described by Liu et al. [7]. Each mouse was injected with
1.7 ml of saline containing circular plasmid DNA or CELiD DNA.
For b-galactosidase activity, 10 mg of pCMV-LacZnls or 1 mg of
CELiD-LacZnls DNA was used. Mice were sacrificed periodically
(1, 3, and 7 days, as well as 5 weeks, post-injection) and liver tissue
collected and snap-frozen in liquid nitrogen for X-gal staining of
tissues. The liver tissues were cryo-sectioned (15 mm thickness),
fixed and X-gal stained according to a standard method [8].
Samples were counter-stained with eosin, dehydrated with
ethanol, and mounted for imaging.
For TBG-GFP gene expression in vivo, 10 mg of either CELiD-
TBG-GFP or circular plasmid pTBG-GFP in 1.7 ml saline was
injected via the tail vein. Mice were sacrificed at 1, 3, and 10 wks
post-injection, and livers samples were processed as above. GFP
expression within the liver sections was detected by fluorescence
microscopy. N = 3 to 4 animals per experimental time point.
In vivo DNA copy number determination
DNA was extracted from transfected liver tissue using the
DNeasy Blood and Tissue kit (Qiagen). Vector copy number was
determined by quantitative PCR (qPCR). TaqMan assays of the
endogenous mouse glucagon gene were used to normalize vector
copy numbers. The sequences of the mouse glucagon gene
primers and probe used were: Glucagon-real-F (mouse), 59-
AAGGGACCTTTACCAGTGATG TG-39; Glucagon-real-R
(mouse), 59-ACTTACTCTCGCCTTCCTCGG-39; TaqMan
mouse glucagon probe, 59-FAM-CAGCAAAGGAATTCA-








Quantitative results are expressed as the mean plus or minus (6)
the standard deviation (SD). Statistical significance analysis of the
data was performed using an unpaired two-sample equal variance
and two-tail distribution Student’s t-test (t-test). A p-value of less
than 0.05 was considered statistically significant as indicated by
asterisks: * p,0.05, ** p,0.01, *** p,0.001.
Results
Characterization of replicative-form vector DNA
produced in stably-transfected Sf9 cell lines
A plasmid (pFBGR-bsd) containing a blasticidin-S deaminase
selectable marker linked to an AAV ITR-flanked green
fluorescent protein (GFP) reporter gene under the regulatory
control of the CMV IE promoter and the baculovirus p10
promoter is shown in Fig. 1. Sf9 cell lines were produced by
transfection with pFBGR-bsd and selection for stable blasticidin-
S deaminase expression. Infection of blasticidin-resistant cells
with a recombinant baculovirus expressing the AAV2 rep gene
(Bac-Rep) induced GFP expression and amplification of the AAV
ITR-flanked GFP transgene in a dose dependent manner (Fig. 2).
In contrast, infection with wild-type baculovirus (Bac-AcNPV)
had no effect on GFP expression. Characterization of the relative
amounts of the Rep and GFP proteins by western blot analysis
combined with quantification of GFP-associated fluorescent
intensity indicated a direct correlation between Rep protein
expression and the induction of GFP activity in infected cells
(Fig. 2B).
To test the hypothesis that Rep protein expression results in
rescue and amplification of the integrated GFP vector genome,
extrachromosomal DNA was extracted from stably transfected
Sf9/ITR-GFP cells and analyzed using quantitative PCR (qPCR)
(Fig. 2C, upper panel) and agarose gel electrophoresis (Fig. 2C,
lower panel). A unit-length 2.7 kb band is apparent in the Bac-
Rep-infected cells, but not in cells infected with wild-type (wt)
baculovirus (Bac-AcNPV). Using qPCR, it was determined that
the copy number of the GFP target sequence increased to greater
than 15,000 copies per cell, in proportion to the amount of Bac-
Rep added to the culture (Fig. 2C, upper panel).
During a time-course experiment, higher doses of Bac-Rep led
to a proportional increase of GFP fluorescence observed on both
day 2 and day 3 post-infection. By day four, the fluorescence
intensity reached a maximum value regardless of the initial
multiplicity of infection (Fig. 2D). The rate of accumulation of
the GFP vector DNA was analyzed using samples of Sf9/ITR-
GFP cells infected with 1% (v:v) of baculovirus-containing
supernatant (Fig. 3A). The GFP vector genome copy number
increased non-linearly over three days. At 168 hr post-infection,
the amount of GFP vector genomes decreased, presumably due
to loss of cell viability. The staining intensities of the monomer
and dimer replicative-form DNAs (2.7 and 5.4 kb, respectively)
(Fig. 3A, lower panel) indicate that the peak level of amplification
occurred at the 55 hr time point. The rate of Rep 78 and Rep
52 expression reached a maximum at 77 hr post-infection, then
declined at 168 hr (17% of 77 hr Rep expression) (Fig. 3B). The
amount of GFP detected by western blot decreased slightly from
77 to 168 hr (69% of 77 hr GFP expression) (Fig. 3B).
stained to detect b-galactosidase activity (indicated by dark blue nuclei). Samples were counterstained with eosin. (C) CELiD-LacZnls and plasmid-
LacZnls copy number per diploid cell in transfected livers. The DNA copy number was normalized based on the PCR quantification of the endogenous
mouse glucagon gene, n = 3 to 4. (D) Comparative long-term transgene expression from constructs bearing a liver specific thyroxine-binding globulin
(TBG) promoter. CELiD-TBG-GFP or plasmid pTBG-GFP gene expression in liver section 10 weeks post-hydrodynamic tail vein injection. (E) CELiD-TBG-
GFP and plasmid pTBG-GFP DNA copy number per diploid cell in transfected livers. The same amount of DNA (10 mg) was administrated by
hydrodynamic injection. Statistical analysis by TTEST. ** indicates P,0.01.
doi:10.1371/journal.pone.0069879.g008
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Characterization of CELiD DNA
Extrachromosomal DNA was extracted from Bac-Rep-infected
Sf9/ITR-GFP cells and resolved on either native or denaturing
agarose gels. Under native conditions, the extrachromosomal
DNA appeared predominantly as monomeric (2.7 kb) and dimeric
(5.4 kb) forms of the vector genome, within a ladder of vector
genome multimers (Fig. 4A). Under denaturing conditions,
however, the extrachromosomal DNA presented predominantly
as approximately 5.4 kb and 10.8 kb bands (Fig. 4B). The change
in mobility under denaturing conditions suggested that the
monomeric and dimeric vector genomes are duplex molecules
with at least one covalently closed end.
To determine whether the ends of the linear ITR-flanked GFP
transgene are covalently closed, extrachromosomal DNA recov-
ered from Sf9/ITR-GFP cells was treated with the restriction
endonuclease AgeI and resolved using either native or denaturing
agarose gel electrophoresis (Fig. 4C) (see also Fig. S1). Following
digestion with AgeI, the extrachromosomal DNA resolved as two
major bands, of 1.8 kb and 0.9 kb, and two minor bands of 3.6 kb
and 1.7 kb (Fig. 4C, right). The 1.8 kb and 0.9 kb bands are as
expected for digestion of a vector genome monomer with AgeI,
whereas the 3.6 kb and 1.7 kb bands are consistent with head-to-
head and tail-to-tail concatamers of multimeric vector genomes
(Fig. 4C, left). Under denaturing conditions, the AgeI digestion
products appeared as just two bands (of 3.6 kb and 1.7 kb). Lack
of the 1.8 kb and 0.9 kb bands suggests that the replicated vector
genomes are covalently closed at both ends of the DNA duplex.
Use of other restriction endonucleases produced results consistent
with this model (Fig. S1).
As second indication of whether the ends of the vector DNA are
covalently closed, isolated extrachromosomal DNA was subjected
to digestion with either E. coli exonuclease I (ExoI) or exonuclease
III (ExoIII). ExoI degrades single-stranded DNA in the 39 to 59
direction [9]. ExoIII progressively degrades duplex DNA in a 39 to
59 direction from 39-recessed or blunt-ended DNA molecules
(substrates with 39 protruding ends greater 4 nt are resistant)
[10,11]. Figure 5 shows that CELiD DNA and circular single-
stranded wX174 DNA were resistant to ExoI digestion, while a
single-stranded, synthetic oligonucleotide or endonuclease HaeIII-
digested wX174 DNA were susceptible. As shown in Fig. 5A,
native CELiD DNA was resistant to ExoIII digestion; however,
after treatment with restriction enzyme NaeI, the vector DNA
became susceptible to ExoIII activity. Together with the
denaturing agarose gel electrophoresis results, these observations
are consistent with a replicative-form DNA bearing a closed-ended
DNA duplex structure.
Atomic Force Microscopy of CELiD – vector DNA
Atomic force microscopy (AFM) was used to visualize purified
CELiD DNA (Fig. 6). The 2.7 kb CELiD-GFP vector genome
appeared as an extended, linear duplex molecule with an
estimated mean contour length of 2701 (6607) base pairs
(Fig. 6A). Results of alkaline agarose gel electrophoresis analysis
predict that, upon denaturation, the 2.7 kb CELiD-GFP mono-
mer should occur as an approximately 5400 base-long, single-
stranded, circular molecule. Although maintaining CELiD DNA
in a single-stranded state proved difficult, several predominantly
single-stranded DNA molecules with closed contours were
observed under denaturing conditions (Fig. 6B). The lengths of
extended DNA chains with clearly discernible paths were
determined by contour tracing and were consistent with a
covalently closed, single-stranded monomer.
AFM analysis of the 5.4 kb CELiD-GFP DNA dimer revealed
an interesting conformation. The termini of the dimer appear as
compacted, tortuous structures with a similar, but less extensive,
structure centrally located (Fig. 6C). The contours of these
molecules could not be traced; however, the lengths were
estimated using total molecular volumes. The calculated DNA
lengths averaged 5480 bp (6310 bp; n = 23) in agreement with
the predicted size of 5336 bp. The positions of the convoluted
regions of the dimer DNA correspond to the locations of the AAV
ITRs. The AAV2 Rep78 protein, required for CELiD-vector
DNA production, has sequence specific DNA binding activity.
Multimers of Rep78 have been shown to non-covalently interact
with a motif repeated in the AAV ITR [12,13]. Western blots of
nuclease-treated CELiD-vector DNA preparations detected the
presence of both Rep78 and Rep52 (Fig. S2). To investigate
whether Rep proteins, or other proteins, binding to the DNA
contributed to the convoluted structures, the ionicity was increased
to potentially disrupt non-covalent protein-DNA interactions. In
the presence of 0.5 molar NaCl, the 5.4 kb CELiD-GFP DNA
transitioned to an extended conformation (Fig. 6D). The lengths of
several such relaxed DNA molecules were measured by contour
tracing (53376118 bp; n = 18), and were consistent with the
lengths estimated for the convoluted forms using the volume per
unit length estimates. The measured lengths agree with the
predicted size of the duplex dimer (5336 bp).
CELiD – vector DNA expression in vitro and in vivo
The ability of CELiD DNA produced in Sf9 cells to direct
transgene expression in vitro was determined using an ITR-flanked
green fluorescent protein reporter cassette (CELiD-GFP, Fig. 7A)
or an ITR-flanked LacZnls (nuclear-localized b-galactosidase)
reporter cassette (CELiD-LacZnls, Fig. 7B). Equivalent copy
numbers of parental GFP plasmid and CELiD-GFP DNA
molecules were used in the in vitro experiments. FACS analysis
of cells transfected with CELiD-GFP or pFBGR (a GFP-
expressing plasmid) showed that the population of positive cells
and expression levels were similar: 39.6% and 31.1% GFP positive
cells and 3656 and 2442 relative fluorescent units for CELiD and
pFBGR-transfected cells, respectively (Fig. 7A). Using equal
weight amounts of DNA, LacZ expression was higher for plasmid
DNA than CELiD DNA in transiently transfected HEK 293 cells
(Fig. 7B).
In vivo gene expression was assessed in outbred ICR male mice
using purified CELiD–LacZnls DNA administered by hydrody-
namic tail vein injection (Fig. 8). Livers from mice injected with
CELiD–LacZnls DNA (1 mg) had detectable levels of b-galacto-
sidase activity at 1 day after injection, and the level of expression
remained relatively constant through day 7. LacZnls activity
could still be detected at 5 weeks post-injection in CELiD–
LacZnls liver section (Fig. 8A). Plasmid pCMV-LacZnls DNA
(10 mg) demonstrated robust expression at day 1, but quickly
diminished over the course of the experiment. Although more
plasmid DNA was injected than CELiD–LacZnls DNA, b-
galactosidase activity in the pCMV-LacZnls-treated liver was not
detectable at 5 weeks (Fig. 8B); however, the CELiD–LacZnls-
treated liver still had detectable LacZnls expression at a similar
time point. Quantitative PCR analysis of vector DNA copy
number in transfected liver tissue showed that more CELiD-
LacZnls DNA was retained in the liver at 5 weeks post-injection
compared to plasmid DNA, and also showed a slower rate of
decline in copy number over time (Fig. 8C). We postulate that
the decline of LacZ expression over time is due primarily to shut-
off of the CMV promoter in the liver. To address this hypothesis,
a GFP reporter gene under the control of the thyroxine-binding
globulin (TBG) promoter, which demonstrates prolonged activity
in hepatocytes [14,15,16], was used to assess long-term gene
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expression in the mouse liver. CELiD-TBG-GFP and the
equivalent plasmid pTBG-GFP DNA (10 mg each) were admin-
istrated to outbred ICR mice by hydrodynamic tail vein
injection. At 10 weeks post-injection, no GFP expression was
evident in the plasmid-treated mice, while GFP expression in
livers of CELiD-TBG-GFP-treated mice was apparent (Fig. 8D).
The CELiD-TBG-GFP expression pattern was predominantly
centrilobular, resembling expression patterns observed in recom-
binant AAV-treated mouse livers [17]. Quantitative analysis of
DNA copy numbers of CELiD-TBG-GFP and plasmid pTBG-
GFP DNA showed very similar levels at 1 wk post-injection
(Fig. 8E). CELID-TBG-GFP DNA copy number remained at
91% at 3 wks and 65% at 10 wks post-injection relative to the
amount of vector DNA present at the 1wk time point, while
plasmid pTBG-GFP DNA copy numbers decreased to 39% at
3 wks and only 1.8% at 10 wks post-injection relative to the 1 wk
pDNA amount. Therefore, the amount of vector DNA in the
liver of CELiD-TBG-GFP-recipient mice was 36-fold higher than
those receiving equivalent plasmid DNA. The differences
between CELiD-TBG-GFP and plasmid pTBG-GFP DNA copy
numbers in transfected livers at 3 wks and 10 wks post-injection
demonstrated statistical significance (P,0.01). The CELiD-TBG-
GFP in vivo data revealed that the levels of CELiD DNA in
mouse liver remained nearly unchanged during a 10 wk period.
Discussion
Non-viral gene delivery circumvents certain disadvantages
associated with viral transduction, particularly those due to the
humoral and cellular immune responses to the viral structural
proteins that form the vector particle [18,19]and any de novo virus
gene expression [2,20]. Plasmids produced in E. coli contain
elements needed for propagation in prokaryotes that are
unnecessary, and even deleterious, for transgene expression in
mammalian cells [21]. In addition to the required cis-elements,
including a prokaryotic origin of DNA replication (e.g., colE1 ori)
and a selectable marker, typically an antibiotic resistance gene
(e.g., b-lactamase), bacterial plasmids bear uniquely prokaryotic
modifications to DNA, such as N6-methyladenine and N5-
methylcytosine [22]. These may elicit undesirable outcomes in an
in vivo application [23]. Relative to mammalian genomic DNA,
the occurrence of CpG dinucleotides in prokaryote-derived
pDNA is overrepresented [24] and reportedly binds a member
of the Toll-like family of receptors, eliciting a T cell-mediated
immune response [25,26,27]. In addition, reducing the amounts
of detrimental impurities, including bacterial genomic DNA and
endotoxins, is critical for production of plasmids used in vivo.
‘‘Mini-circle’’ DNA, a recent improvement to the production of
pDNA free of prokaryotic cis-acting elements, uses an inducible
recombinase to specifically delete the prokaryotic moiety from the
bacterial mini-circle shuttle plasmid [28,29]. Mini-circle DNAs
have been used in vivo for long-term gene expression in mice, and
for generating induced pluripotent stem cells (iPSC) in vitro [30].
Another alternative to pDNA is mini-linear, covalently closed
(mini-lcc) DNA that possesses all the benefits of ‘‘mini-circle’’
DNA vectors and effectively eliminates the potential for undesir-
able vector integration events [31]. However, both mini-circle and
mini-lcc DNA are produced in prokaryotes. We have described an
alternative method for the high-yield production of eukaryote-
derived, prokaryotic-sequence-free DNA for gene transfer. CE-
LiD-vector DNA consists solely of a therapeutic or reporter gene
transcription unit and the AAV2 ITRs. The cis-acting elements
and trans-acting requirements needed for propagating the parental
plasmid in E. coli are eliminated from the CELiD ‘‘rescue’’ and
replication process. The genetic organization of CELiD-vector
DNA, resembles rAAV vector DNA, but differs in conformation.
The encapsidated recombinant AAV vector genome is predom-
inantly a unique sequence of linear single-stranded DNA, although
self-complementary forms are packaged either by designing a
vector genome with a defective ITR [32,33,34], or through
natural processes whereby half wild-type-length genomes are
packaged as self-complementary DNA [35]. Unlike encapsidated
AAV vector genomes, CELiD-vector DNA has no packaging
constraints imposed by the limiting space within the viral capsid.
In theory, the only size limitation resides in the DNA replication
efficiency of the host cell. Infection of a stable cell line bearing an
integrated copy of a 2.7 kb GFP vector DNA with a Rep-
expressing baculovirus can yield up to 60 mg of CELiD-vector
DNA from 4.76109cells. This quantity of CELiD DNA represents:
1) $4 million copies per cell, 2) approximately 15– times the mass
of the cellular genomic DNA, and 3) approximately 0.36% of the
cell mass. Thus, CELiD-vector DNA represents a viable eukary-
otic alternative to prokaryote-produced pDNA.
CELiD as a biological replicative intermediate
Autonomous, linear DNA replicons with covalently closed ends
(i.e., terminal hairpins) have been identified in a wide variety of
prokaryotic and eukaryotic organisms. Examples include certain
large DNA viruses of eukaryotes (such as poxviruses and African
swine fever virus), as well as various temperate phage of gram-
negative bacteria (such as N15 and wKO2 of Escherichia coli and
Klebsiella oxytoca, respectively). Additionally, linear plasmids and
chromosomes bearing covalently closed ends have been described
in Agrobacterium tumefaciens and various spirochete species of the
genus Borrelia. Linear replicon-encoded trans-acting factors respon-
sible for terminal hairpin formation have been identified and
biochemically characterized. In particular, the ResT protein of
Borrelia and the TelN protein of phage N15 have been extensively
examined (reviewed in [36,37]). We have demonstrated that a
transgene sequence flanked by adeno-associated virus inverted
terminal repeats (i.e., CELiD DNA) is maintained within S.
fugiperda insect cells as a covalently closed, linear DNA molecule
that serves as an AAV Rep protein-dependent replicon. Interest-
ingly, the large AAV Rep proteins share biochemical activities
with the ResT and TelN proteins, including DNA binding activity,
tyrosine-mediated phosphodiesterase activity and the ability to join
cleaved DNA strands [38,39,40,41,42]. We postulate that Rep-
mediated DNA cleavage-joining activity is responsible for gener-
ation of the covalently closed DNA structure observed for CELiD
DNA.
Perhaps the best-known examples of covalently closed linear
replicons in eukaryotes are those of the Poxviridae. Poxvirus DNA
replication bears similarities to that of the Parvoviridae (including the
dependoviruses such as AAV). DNA replication in both virus
families initiates by enzymatic nicking of one of the terminal
hairpins flanking each end of the linear genome [43,44]. The
nicking event provides a 39-hydroxyl group to prime strand-
displacement replication. In addition to providing a self-priming
DNA element to initiate DNA synthesis, covalently closed terminal
hairpin structures may protect the linear DNA elements from
attack by cellular exonucleases, as well as inhibit illegitimate
recombination events. The role, if any, that closed-ended
replicative forms play in wild-type AAV replication remains to
be determined.
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Supporting Information
Figure S1 Restriction endonuclease digestion products
resolved using native and alkaline agarose gel electro-
phoresis. (A) Native (1% agarose, TBE) and (B) denaturing
(0.7% agarose, alkaline) gel electrophoresis. For both gels, CELiD-
GFP DNA samples in lanes 1–6 were digested with the following
restriction endonucleases. Lane 1: AgeI (monomer endonuclease
recognition site is at position 1801, fragment sizes 1801/867 bp).
Lane 2: SpeI (recognition site is at position 2456, fragment sizes
2456/212 bp). Lane 3: XhoI (recognize site is at position 493,
fragment sizes 493/2175 bp). Lane 4: KpnI (recognize site is at
position 410, fragment sizes 414/2254 bp). Lane 5: NotI
(recognize sites at positions 195 and 2471, fragment sizes 195/
2471/196 bp). Lane 6: XbaI (recognize sites for monomer at
positions 188 and 2479, fragment sizes 188/2479/189 bp). Lane
7: undigested CELiD-GFP DNA. Monomer CELiD-GFP full-
length size = 2668 bp. (C) Table of predicted restriction
endonuclease digestion products. AgeI, SpeI, XhoI and KpnI
have single recognition sites, whereas NotI and XbaI have two
recognition sites in the CELiD-GFP monomer sequence. Diges-
tion products resolved using native agarose gel electrophoresis
produced DNA fragments predicted by the rAAV-GFP (and
corresponding CELiD) map, listed in the table by fragment length
(x, y, or z) in basepairs. The denaturing, alkaline agarose gel
products were 2x and 2y nucleotides in length for the single-cut
enzymes, whereas the double-cut enzymes produced 2x and 2z
length products, and an internal product y that appears the same
size on both native and denaturing gels. Schematic representation
of (D) single-cut and (E) double-cut restriction enzyme sites in
monomer and dimer forms of CELiD vector DNA. The open
boxes indicate the positions of the AAV ITRs. The horizontal
arrow, collinear with CELiD vector DNA, indicates the direction
of the upper, sense-strand in panels D and E. The two dimer
figures represent tail-to-tail and head-to-head configurations. A
tandem head-to-tail configuration would produce x+y fragments,
which were not detected.
(TIF)
Figure S2 Anti-Rep protein western blot of CELiD-GFP
DNA samples treated with Serratia marcescens endonu-
clease. CELiD-GFP DNA samples were treated with 6.7 units of
S. marcescens endonuclease (Turbonuclease, Accelegen, Inc., San
Diego, CA, USA) (except for the material in lane 5, which was
treated with 26.8 units) at 37uC for 30 min prior to SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and western
blotting. The quantities of CELiD-GFP DNA treated with
endonuclease were as follows: Lane 1: 8 mg; lane 2: 16 mg; lane
3: 32 mg; lane 4: 64 mg; lane 5: 64 mg. After SDS-PAGE, proteins
were electrophoretically transferred to a nitrocellulose membrane
and probed with an anti-Rep monoclonal antibody as described in
Materials and Methods, except that a 1:2000 dilution of the
secondary detection antibody was used.
(TIF)
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